Literature DB >> 809050

Responses of an experimental solid tumour to irradiation: A comparison of modes of fractionation.

L L Schenken, L Poulakos, R F Hagemann.   

Abstract

Several radiotherapeutic schedules compatible with continued structural-functional integrity of the gastrointestinal (GI) mucosa were compared utilizing the P815X2 murine mastocytoma grown as a solid subcutaneous tumour. Both the tumour and underlying normal tissues were irradiated during the treatments. The tumour exhibited a Do that increased from 210 rad to 397 rad as the tumour aged and in all instances demonstrated minimal shoulders in survival curves. In spite of a relative radioresistance of cells within the solid tumour, quite effective control of localized disease could be accomplished with radiotherapy schemes compatible with GI tolerance limits. Schedules evaluated utilizing this model included acute exposures to 1122 rad, daily exposure to 187 rad, 5 days/week exposures to 281 rad, twice weekly exposures (561 rad on Mondays and 374 rad on Thursdays) and a high dose, two fractions per day, schedule. Tumours were followed for changes in growth patterns during these schedules. Efficacy of tumour control was determined and schedules were compared on this basis. Aggressive radiotherapy approaching the tolerance limits of any of the fractionation schemes proved most effective.

Entities:  

Mesh:

Year:  1975        PMID: 809050      PMCID: PMC2009365          DOI: 10.1038/bjc.1975.29

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

1.  Effects of single-dose partial-body x-irradiation on cell proliferation in the mouse small intestinal epithelium.

Authors:  J Lesher; S Lesher
Journal:  Radiat Res       Date:  1974-01       Impact factor: 2.841

2.  QUANTITATIVE COLONIAL GROWTH OF MAMMALIAN CELLS IN FIBRIN CELLS.

Authors:  R SCHINDLER
Journal:  Exp Cell Res       Date:  1964-05       Impact factor: 3.905

3.  Culture of neoplastic mast cells and their synthesis of 5-hydroxytryptamine and histamine in vitro.

Authors:  R SCHINDLER; M DAY; G A FISCHER
Journal:  Cancer Res       Date:  1959-01       Impact factor: 12.701

4.  A transplantable mast-cell neoplasm in the mouse.

Authors:  T B DUNN; M POTTER
Journal:  J Natl Cancer Inst       Date:  1957-04       Impact factor: 13.506

5.  Tumor chemotherapy: efficacy dependent on mode of growth.

Authors:  R F Hagemann; L L Schenken; S Lesher
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

6.  Intestinal crypt survival and total and per crypt levels of proliferative cellularity following irradiation: role of crypt cellularity.

Authors:  R F Hagemann; C P Sigdestad; S Lesher
Journal:  Radiat Res       Date:  1972-06       Impact factor: 2.841

7.  Escape from isoantiserum inhibition of lymphocyte-mediated cytotoxicity.

Authors:  R B Faanes; Y S Choi; R A Good
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

  7 in total
  2 in total

Review 1.  Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Authors:  Anish Prasanna; Mansoor M Ahmed; Mohammed Mohiuddin; C Norman Coleman
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy.

Authors:  Alan Pollack; Felix M Chinea; Elizabeth Bossart; Deukwoo Kwon; Matthew C Abramowitz; Charles Lynne; Merce Jorda; Brian Marples; Vivek N Patel; Xiaodong Wu; Isildinha Reis; Matthew T Studenski; Javier Casillas; Radka Stoyanova
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-02-19       Impact factor: 7.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.